Source Search Page
globenewswire.com > news-release > en
Outdoor Power Equipment Market To Reach USD 80.8 Billion By 2032, Says DataHorizzon Research
23+ min ago —...of Landscape Architects (ASLA) noting that professional landscaping... ..., April 26, 2024 (GLOBE NEWSWIRE) -- The rise in demand for landscaping... ...Market 2024 to 2032 Rough Terrain Lift Truck Market 2024 to 2032 Mobile...
globenewswire.com > news-release > en
Introducing Altcat: Your AI Girlfriend Experience with Your Favorite Influencer
1+ hour, 14+ min ago —...April 26, 2024 05:38 ET | Source: Altcat Altcat LOS ANGELES, April... ...Zenon, the founder of Altcat, asserts that this technology will revolutionize... ...and Amara Mila praising the realistic and enhanced versions... ...noted the uncanny resemblance, with prominent OnlyFans creators Cathy Zhao...
globenewswire.com > news-release > en
Amendment of the terms concerning Convertible Bonds 2021/1, 2021/2, 2021/3, 2021/4 and 2022/1 issued by Digitalist Group Plc...
53+ min ago —...Digitalist Group Oyj Stock Exchange Release 26 April 2024 at 13:00... ...Group Plc ("Digitalist Group" or the âCompany") and Turret Oy... ...of Convertible Bond 2021/1.The maximum total number of new Digitalist... ...of Convertible Bond 2022/1;The maximum total number of new Digitalist...
globenewswire.com > news-release > en
Byrna Technologies Promotes John Brasseur to Chief Operating Officer and Raises Production Target to 18,000 Launchers per Month...
22+ hour, 53+ min ago —...John Brasseur, who joined Byrna in July of last year as Vice President... ...of New Product Development, has been promoted to Chief Operating... ...“I am honored to step into the role of Chief Operating Officer at... ...About Byrna Technologies Inc.Byrna is a technology company specializing...
globenewswire.com > fr > news-release > en
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts...
23+ hour, 53+ min ago —...Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director... ...New Non-Executive Director of the Board, John Davis MD, MPH, MS,... ...Nucleome’s Scientific Advisory Board (SAB): Blobel MD, PhD, is the... ...University of Sheffield Iain Kilty, PhD, is CSO at Sitryx Therapeutics...
globenewswire.com > news-release > en
Whey Protein Market To Reach USD 16.8 Billion By 2032, Says DataHorizzon Research
1+ hour, 53+ min ago —...Source: DataHorizzon Research DataHorizzon Research Fort Collins, Colorado... ...Another significant growth driver in the fitness and wellness sector...
globenewswire.com > fr > news-release > en
Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination...
22+ hour, 53+ min ago —...2024 08h00 HE | Source: SDS Optic S.A.... ...targeted therapy. 1 Current paradigm of HER2 expression scoring [1] SDS Optic... ...Zhang H, Peng Y.... ...This novel in vivo approach allows the examination with optic fiber...
globenewswire.com > news-release > en
Media Update: New data presented at ATS demonstrate Sanofi’s leadership in advancing potential new therapies for patients with immune-mediated respiratory diseases...
5+ hour, 53+ min ago —...April 26, 2024 01:00 ET | Source: Sanofi - Aventis Groupe Sanofi... ...- Aventis Groupe New data presented at ATS demonstrate Sanofi’s leadership... ...Food and Drug Administration as an add-on maintenance treatment in... ...Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY Sanofi Media RelationsSally...
globenewswire.com > fr > news-release > en
Golden Triangle Ventures Announces Four-Pillar Business Model for Lavish Entertainment
22+ hour, 53+ min ago —...LAS VEGAS, April 25, 2024 (GLOBE NEWSWIRE) -- via IBN -- Golden Triangle... ...2024 08h00 HE | Source: Golden Triangle Ventures, Inc.... ...Golden Triangle Ventures’ business model is supported by the drive... ...About Golden Triangle Ventures, Inc. or “GTV” is a multifaceted consulting...
globenewswire.com > news-release > de
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension...
5+ hour, 53+ min ago —...Clozel, MD and Chief Executive Officer of Idorsia commented:“Uncontrolled... ..., heart failure, stroke, end-stage renal disease and death.4 Jean-Paul... ...America, Asia, and Australia.... ...study, which was performed in hospitals or research centers in Europe, North...